Topical Drug Development for Immune Mediated Skin Diseases

Time: 2:30 pm
day: Day 1 PM - Track 2

Details:

• Understanding disease pathogenesis
• Examining formulation development
• Discussing the clinical development pathway
• Evaluating the life cycle strategy

Speakers: